Iobenguane Approved for Marketing Phase N/A Trials for Neuroblastomas

IndicationsStatusPurposePhase
Approved for MarketingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00730444Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma